Literature DB >> 26737770

Performance comparison of Next Generation sequencing platforms.

Bekir Erguner, Duran Ustek, Mahmut S Sagiroglu.   

Abstract

Next Generation DNA Sequencing technologies offer ultra high sequencing throughput for very low prices. The increase in throughput and diminished costs open up new research areas. Moreover, number of clinicians utilizing DNA sequencing keeps growing. One of the main concern for researchers and clinicians who are adopting these platforms is their sequencing accuracy. We compared three of the most commonly used Next Generation Sequencing platforms; Ion Torrent from Life Technologies, GS FLX+ from Roche and HiSeq 2000 from Illumina.

Entities:  

Mesh:

Year:  2015        PMID: 26737770     DOI: 10.1109/EMBC.2015.7319870

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  3 in total

Review 1.  Genomic, proteomic, and systems biology approaches in biomarker discovery for multiple sclerosis.

Authors:  Carol Chase Huizar; Itay Raphael; Thomas G Forsthuber
Journal:  Cell Immunol       Date:  2020-09-20       Impact factor: 4.868

2.  Mutational profile of rare variants in inflammasome-related genes in Behçet disease: A Next Generation Sequencing approach.

Authors:  Sergio Burillo-Sanz; Marco-Antonio Montes-Cano; José-Raúl García-Lozano; Lourdes Ortiz-Fernández; Norberto Ortego-Centeno; Francisco-José García-Hernández; Gerard Espinosa; Genaro Graña-Gil; Juan Sánchez-Bursón; María Rosa Juliá; Roser Solans; Ricardo Blanco; Ana-Celia Barnosi-Marín; Ricardo Gómez De la Torre; Patricia Fanlo; Mónica Rodríguez-Carballeira; Luis Rodríguez-Rodríguez; Teresa Camps; Santos Castañeda; Juan-Jose Alegre-Sancho; Javier Martín; María Francisca González-Escribano
Journal:  Sci Rep       Date:  2017-08-16       Impact factor: 4.379

Review 3.  Fish as predators and prey: DNA-based assessment of their role in food webs.

Authors:  Michael Traugott; Bettina Thalinger; Corinna Wallinger; Daniela Sint
Journal:  J Fish Biol       Date:  2020-07-08       Impact factor: 2.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.